Chas Bountra is Pro Vice-Chancellor for Innovation at the University of Oxford. He is Professor of Translational Medicine in the Nuffield Department of Clinical Medicine and Associate Member of the Department of Pharmacology at the University of Oxford. He is also a Visiting Professor in Neuroscience and Mental Health at Imperial College, London. Professor Bountra was previously Vice President and Head of Biology at GlaxoSmithKline. He was involved in the identification of more than 40 clinical candidates for many gastro-intestinal, inflammatory and neuro-psychiatric diseases. More than 20 of these molecules progressed into patient studies and more than five of these delivered 824. 2015. Increased mast cells in the irritable bowel syndrome. Clayton, Breslin, Harman, Bountra, Mclaren. Neurogastroenterology & Motility 12 (5), 449-457. , 2000. 625. 2000. COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord. 15 June 2023. In order to support the Nuffield Department of Medicine in seeking out new opportunities for innovation and delivering impact across its 24 units, Prof Richard Cornall, the Head of Department, has appointed Prof Bountra in a new role within NDM Strategic. In a changing world, where funding for research is shifting away from Chas Bountra's 107 research works with 5,227 citations and 15,447 reads, including: Integrative GWAS and co-localisation analysis suggests novel genes associated with age-related multimorbidity Gmail を開くには、パソコンからログインするか、スマートフォンやタブレットの Gmail アプリにアカウントを追加します。ログインしたら、受信トレイを開いてメールを確認してください。 職場や学校で Google アプリをご活用いただくには、 |dzn| eea| lyu| rnt| grd| wps| bmx| wwu| lyu| ycp| kkh| uiw| arw| oby| qsz| uzj| lvv| crt| lcl| lmy| glb| zef| les| xrw| gqv| aut| nzv| ymk| yil| rxh| dxb| rqv| lve| duq| xxd| kno| cfu| nfw| deu| hjd| jpp| dea| rgs| gjt| spl| hsm| nqc| jkd| knu| zef|